DCF — JERSEY SHORE UNIVERSITY MED CTR
Enterprise Value: $794.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$794.8M
Enterprise Value
$204.4M
PV of Cash Flows
$590.5M
PV of Terminal Value
$950.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.2B | $107.2M | 9.0% | $37.0M | $33.6M |
| Year 2 | $1.2B | $122.8M | 10.0% | $47.4M | $39.2M |
| Year 3 | $1.3B | $139.3M | 11.0% | $58.4M | $43.9M |
| Year 4 | $1.3B | $150.0M | 11.0% | $65.1M | $44.5M |
| Year 5 | $1.4B | $157.9M | 12.0% | $69.6M | $43.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $794.8M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.2B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08410012717409565
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5